NOREPINEPHRINE Drug Patent Profile
Which patents cover Norepinephrine, and what generic alternatives are available?
Norepinephrine is a drug marketed by Adaptis, Amneal, Aspiro, Baxter Hlthcare Corp, Biocon Pharma, Breckenridge, Caplin, Fresenius Kabi Usa, Gland, Hikma, Meitheal, Metrics Pharm, MSN, Mylan Labs Ltd, Nephron, Rising, Sandoz, Sun Pharm, Zydus Pharms, Inforlife, Long Grove Pharms, and Sagent. and is included in twenty-five NDAs. There are thirteen patents protecting this drug.
The generic ingredient in NOREPINEPHRINE is norepinephrine bitartrate. There is one drug master file entry for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the norepinephrine bitartrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Norepinephrine
A generic version of NOREPINEPHRINE was approved as norepinephrine bitartrate by MEITHEAL on March 3rd, 2003.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for NOREPINEPHRINE?
- What are the global sales for NOREPINEPHRINE?
- What is Average Wholesale Price for NOREPINEPHRINE?
Summary for NOREPINEPHRINE
| US Patents: | 0 |
| Applicants: | 22 |
| NDAs: | 25 |
| Drug Prices: | Drug price information for NOREPINEPHRINE |
| What excipients (inactive ingredients) are in NOREPINEPHRINE? | NOREPINEPHRINE excipients list |
| DailyMed Link: | NOREPINEPHRINE at DailyMed |


